TCL Archive ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7 May 27, 2011
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light December 5, 2014
TCL Archive As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel. October 20, 2000